What is WeGovy?

With all the recent chatter online and in the news about WeGovy and its incredible results, it’s no wonder people looking to shed weight are interested in hearing about what WeGovy actually is. Here at Bodyline Wellness Clinics, we’re happy to assist in offering the latest and greatest in medical weight loss information and guidance, so buckle up as you find out: what is WeGovy?

WeGovy or Ozempic?

WeGovy and Ozempic are both medications used in the treatment of type 2 diabetes. They both contain the active ingredient semaglutide, which belongs to a class of drugs called GLP-1 receptor agonists. GLP-1 receptor agonists work by mimicking the effects of a natural hormone called glucagon-like peptide-1 (GLP-1) in the body.

WeGovy is a once-weekly injection. It is manufactured by Novo Nordisk in the US, the same company that produces Ozempic, also an injection administered once a week. WeGovy has essentially been remarketed as a weight loss solution for obesity as opposed to type 2 diabetes. Both medications have been seen to reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with obesity and/or type 2 diabetes.

However, the incredible result that comes alongside these health benefits is a health transformation and drastic weight loss. Studies have shown that users of Ozempic/WeGovy saw an average loss of 15% of their overall body weight! This medication has helped people with BMI’s listed under obese to reach healthy BMI’s, even if they’ve spent years trying beforehand.

Ozempic is offered as an aid to help people suffering from obesity with a healthy diet and exercise regime, as well as to improve glycaemic control in those suffering from diabetes. It is also approved to reduce the risk of major adverse cardiovascular events.

How does WeGovy work?

Both WeGovy and Ozempic work by stimulating the release of insulin from the pancreas in response to meals, reducing the amount of glucose produced by the liver, and slowing down the emptying of food from the stomach. This helps to lower blood sugar levels and improve glycemic control in people with type 2 diabetes.

In addition to their glucose-lowering effects, both WeGovy and Ozempic have been shown to promote weight loss. This is believed to be due to their ability to reduce appetite and food intake, as well as their effects on the metabolism.

Is WeGovy available in the UK?

It’s worth noting that while WeGovy and Ozempic share many similarities, there are some key differences between the two medications. For example, WeGovy is a higher-dose formulation of semaglutide compared to Ozempic. WeGovy as a brand is higher in price and is not currently available to people in the UK. 

Luckily, here at Bodyline we are excited to offer the game changing Ozempic Slimming Pen as part of our medical weight loss programmes! WeGovy will be available shortly. This allows clients to make use of WeGovy’s incredible weight loss results here in the UK and reach their goal weight quickly and safely.

Where can I buy WeGovy?

Start your medical weight loss journey today

There will be lots of websites online that will be trying to sell medication called WeGovy in the UK, but please note that these online pharmacies may not be regulated or safe.

At Bodyline Wellness Clinics, we source our Ozempic Slimming Pen from safe and secure UK laboratories, and we are regulated by the CQC – the same people who regulate the NHS hospitals and general practices.

Over 100,000 people have come to us and used our expertise and experience to help them in their weight loss journeys. You can too! If you’re interested in making use of WeGovy’s active ingredient in your goal to a healthier you, call us today on 0800 995 6036 or fill in our online contact form for a call back. 

You can see the same results as American WeGovy users, just in time for summer!

Start your medical weight loss journey today

Related blog posts

Despite the enormous popularity of WeGovy and its incredible impact on weight loss, a shortage of the injectable weight loss therapy has been ongoing in recent months. The semaglutide-containing injection has been dubbed “game-changing” for the treatment of obesity, and demand has been high, but manufacturer Novo Nordisk has struggled to keep up and has only released limited stock.
Mounjaro, also known as tirzepatide, is an innovative prescription medication that has shown great potential in promoting weight loss in clinical trials. Due to rising levels of obesity, and therefore increasing need for treatments, many people are rushing to try game-changing medications like Mounjaro to solve their problems.
In recent years, GLP-1 receptor agonists, also known as GLP-1s, have gained significant attention for their potential in promoting weight loss. These medications, including Ozempic and Saxenda, were originally developed for the treatment of type 2 diabetes but have also shown promising results in helping individuals achieve their weight loss goals.


Contact Bodyline to find out more how we can treat and support you to improve your health and wellbeing.

"*" indicates required fields

Select the Bodyline treatment that you would like to discuss*
By submitting this form you agree to the Bodyline privacy policy.